Neuropsychiatric manifestations in patients with systemic lupus erythematosus: Epidemiology and radiology pointing to an immune-mediated cause

Annals of the Rheumatic Diseases

Volumn 72, Issue SUPPL. 2, 2013, Pages

  Steup Beekman, Gerda M ^a   Zirkzee, Elisabeth J M ^a   Cohen, Danielle ^a   Gahrmann, Bastiaan M A ^a   Emmer, Bart J ^a   Steens, Stefan C A ^a   Bollen, Eduard L E M ^a   Van Buchem, Mark A ^a   Huizinga, Tom W J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; AZATHIOPRINE; CYCLOPHOSPHAMIDE; METHYLPREDNISOLONE; PREDNISONE;

ACUTE CONFUSION; ADULT; ANXIETY DISORDER; ARTICLE; ASEPTIC MENINGITIS; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; COHORT ANALYSIS; CRANIAL NEUROPATHY; DRUG MEGADOSE; FEMALE; GUILLAIN BARRE SYNDROME; HEADACHE; HUMAN; IMMUNOPATHOGENESIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; MENTAL DISEASE; MONONEUROPATHY; MOOD DISORDER; MOTOR DYSFUNCTION; NEUROLOGIC DISEASE; NEUROPSYCHIATRIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYNEUROPATHY; PREVALENCE; PRIORITY JOURNAL; PSYCHOSIS; RETROSPECTIVE STUDY; SEIZURE; SPINAL CORD DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

ADOLESCENT; ADULT; COHORT STUDIES; FEMALE; GLUCOCORTICOIDS; HUMANS; IMMUNE SYSTEM DISEASES; LUPUS VASCULITIS, CENTRAL NERVOUS SYSTEM; MAGNETIC RESONANCE IMAGING; MALE; PREVALENCE; RETROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84876295032     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/annrheumdis-2012-202369     Document Type: Article

References (33)

1. Bresnihan B. Outcome and survival in systemic lupus erythematosus. Ann Rheum Dis 1989;48:443-5.
2. Cervera R, Khamashta MA, Font J, et al. Morbidity and mortality in systemic lupus erythematosus during a 10-year period: a comparison of early and late manifestations in a cohort of 1,000 patients. Medicine (Baltimore) 2003;82:299-308. (Pubitemid 37229465)
3. Ainiala H, Loukkola J, Peltola J, et al. The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus. Neurology 2001;57:496-500. (Pubitemid 32757599)
4. Brey RL, Holliday SL, Saklad AR, et al. Neuropsychiatric syndromes in lupus: prevalence using standardized definitions. Neurology 2002;58:1214-20. (Pubitemid 34411865)
5. Jennekens FG, Kater L. The central nervous system in systemic lupus erythematosus. Part 1. Clinical syndromes: a literature investigation. Rheumatology (Oxford) 2002;41:605-18. (Pubitemid 34618878)
6. Ainiala H, Dastidar P, Loukkola J, et al. Cerebral MRI abnormalities and their association with neuropsychiatric manifestations in SLE: a population-based study. Scand J Rheumatol 2005;34:376-82. (Pubitemid 41545911)
7. Sibbitt WL Jr, Sibbitt RR, Brooks WM. Neuroimaging in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 1999;42:2026-38. (Pubitemid 30263585)
8. ACR Ad Hoc Committee on neuropsychiatric lupus nomenclature. The American College of Rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arthritis Rheum 1999;42:599-608.
9. Hanly JG, McCurdy G, Fougere L, et al. Neuropsychiatric events in systemic lupus erythematosus: attribution and clinical significance. J Rheumatol 2004;31:2156-62. (Pubitemid 39453234)
10. Rood MJ, Breedveld FC, Huizinga TW. The accuracy of diagnosing neuropsychiatric systemic lupus erythematosus in a series of 49 hospitalized patients. Clin Exp Rheumatol 1999;17:55-61. (Pubitemid 29099888)
11. Ellis SG, Verity MA. Central nervous system involvement in systemic lupus erythematosus: a review of neuropathologic findings in 57 cases, 1955-1977. Semin Arthritis Rheum 1979;8:212-21. (Pubitemid 9104125)
12. Abbott NJ, Mendonca LL, Dolman DE. The blood-brain barrier in systemic lupus erythematosus. Lupus 2003;12:908-15. (Pubitemid 38082086)
13. DeGiorgio LA, Konstantinov KN, Lee SC, et al. subset of lupus anti-DNA antibodies cross-reacts with the NR2 glutamate receptor in systemic lupus erythematosus. Nat Med 2001;7:1189-93. (Pubitemid 33063773)
14. Huerta PT, Kowal C, DeGiorgio LA, et al. Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci U S A 2006;103:678-83. (Pubitemid 43153085)
15. Kowal C, DeGiorgio LA, Nakaoka T, et al. Cognition and immunity; antibody impairs memory. Immunity 2004;21:179-88. (Pubitemid 39094048)
16. Emmer BJ, van der Grond J, Steup-Beekman GM, et al. Selective involvement of the amygdala in systemic lupus erythematosus. PLoS Med 2006;3:e499.
17. Harrison MJ, Ravdin LD, Lockshin MD. Relationship between serum NR2a antibodies and cognitive dysfunction in systemic lupus erythematosus. Arthritis Rheum 2006;54:2515-22. (Pubitemid 44205012)
18. Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997;40:1725.
19. Tan EM, Cohen AS, Fries JF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7. (Pubitemid 13221242)
20. Wilson WA, Gharavi AE, Koike T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome: report of an international workshop. Arthritis Rheum 1999;42:1309-11. (Pubitemid 30265586)
21. Shimojima Y, Matsuda M, Gono T, et al. Relationship between clinical factors and neuropsychiatric manifestations in systemic lupus erythematosus. Clin Rheumatol 2005;24:469-75. (Pubitemid 43055036)
22. Hanly JG, Urowitz MB, Sanchez-Guerrero J, et al. Neuropsychiatric events at the time of diagnosis of systemic lupus erythematosus: an international inception cohort study. Arthritis Rheum 2007;56:265-73. (Pubitemid 46106200)
23. Hanly JG, Urowitz MB, Su L, et al. Prospective analysis of neuropsychiatric events in an international disease inception cohort of SLE patients. Ann Rheum Dis 2010;69:529-35.
24. Arbuckle MR, McClain MT, Rubertone MV, et al. Development of autoantibodies before the clinical onset of systemic lupus erythematosus. N Engl J Med 2003;349:1526-33. (Pubitemid 37255038)
25. Luyendijk J, Steens SC, Ouwendijk WJ, et al. Neuropsychiatric systemic lupus erythematosus: lessons learned from magnetic resonance imaging. Arthritis Rheum 2011;63:722-32.
26. Bosma GP, Rood MJ, Huizinga TW, et al. Detection of cerebral involvement in patients with active neuropsychiatric systemic lupus erythematosus by the use of volumetric magnetization transfer imaging. Arthritis Rheum 2000;43:2428-36.
27. Bosma GP, Middelkoop HA, Rood MJ, et al. Association of global brain damage and clinical functioning in neuropsychiatric systemic lupus erythematosus. Arthritis Rheum 2002;46:2665-72. (Pubitemid 36118930)
28. Emmer BJ, Steup-Beekman GM, Steens SC, et al. Correlation of magnetization transfer ratio histogram parameters with neuropsychiatric systemic lupus erythematosus criteria and proton magnetic resonance spectroscopy: association of magnetization transfer ratio peak height with neuronal and cognitive dysfunction. Arthritis Rheum 2008;58:1451-7. (Pubitemid 351705934)
29. Cohen D, Nabuurs RJ, Steup-Beekman GM, et al. Nationwide autopsy study links complement to thrombo-ischemia in neurolupus. In Press.
30. Brey RL. Antiphospholipid antibodies in young adults with stroke. J Thromb Thrombolysis 2005;20:105-12. (Pubitemid 41554443)
31. Hanly JG, Hong C, Smith S, et al. A prospective analysis of cognitive function and anticardiolipin antibodies in systemic lupus erythematosus. Arthritis Rheum 1999;42:728-34. (Pubitemid 29171993)
32. Mikdashi J, Handwerger B. Predictors of neuropsychiatric damage in systemic lupus erythematosus: data from the Maryland lupus cohort. Rheumatology (Oxford) 2004;43:1555-60. (Pubitemid 39642582)
33. Steens SC, Bosma GP, Steup-Beekman GM, et al. Association between microscopic brain damage as indicated by magnetization transfer imaging and anticardiolipin antibodies in neuropsychiatric lupus. Arthritis Res Ther 2006;8:R38.